A Message from the ESMO President By Ogkologos - March 17, 2020 647 0 Facebook Twitter Google+ Pinterest WhatsApp Source RELATED ARTICLESMORE FROM AUTHOR Giredestrant plus everolimus prolongs PFS among patients with ER-positive, HER2-negative, ESR1-mutated advanced breast cancer after the receipt of a CDK4/6 inhibitor EMA Recommends Granting a Marketing Authorisation for Ensartinib Taking on the RAS Challenge MOST POPULAR No improvement in OS, but more grade 3 or higher AEs... September 24, 2026 “The power of science”: HPV vaccine proven to dramatically reduce cervical... November 3, 2021 EMA Recommends Extension of Indications for Acalabrutinib to Include the Treatment... April 3, 2025 EMA Recommends Granting a Marketing Authorisation for Zolbetuximab August 28, 2024 Load more HOT NEWS New Blood Test Can Screen For Over 50 Cancers ESMO Welcomes European Parliament (EP) Draft Report on Psychosocial Risks at... Coping with COVID: New Stimulus Funds and Unemployment Benefit Update FDA Approval of Rylaze Will Address Drug Shortage for Childhood ALL
